Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 6Breast Neoplasms 2Small Cell Lung Carcinoma 1Recurrence 1Prostate Cancer Metastatic 1Neoplasm Metastasis 1Metastatic Breast Cancer With Intracranial Metastases 1Lung Neoplasms 1Hormone-Resistant Prostate Cancer 1Diarrhea 1Castrate-resistant Metastatic Prostate Cancer 1Carcinoma, Transitional Cell 1Brain Neoplasms 1

Interventions

prednylidene 1deltacortene 1cabazitaxel 1XRP6258 1Prednisone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Hormone-Resistant Prostate Cancer × XRP6258 × Clear all
NCT02844582 2021-01-25

Cabazitaxel and Prednisone in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer

University of California, Davis

Phase 2 Terminated
2 enrolled 5 charts
Genitourinary

Hormone-Resistant Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡